These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19690147)

  • 1. Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation.
    Brady SC; Coleman ML; Munro J; Feller SM; Morrice NA; Olson MF
    Cancer Res; 2009 Sep; 69(17):6773-81. PubMed ID: 19690147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA; DeNicola GM; Winter SP; Tuveson DA
    Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
    Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
    Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
    Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling.
    Nguyen D; Lin LY; Zhou JO; Kibby E; Sia TW; Tillis TD; Vapuryan N; Xu MR; Potluri R; Shin Y; Erler EA; Bronkema N; Boehlmer DJ; Chung CD; Burkhard C; Zeng SH; Grasso M; Acevedo LA; Marmorstein R; Fera D
    Biochemistry; 2020 Dec; 59(50):4755-4765. PubMed ID: 33272017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein.
    Brummer T; Martin P; Herzog S; Misawa Y; Daly RJ; Reth M
    Oncogene; 2006 Oct; 25(47):6262-76. PubMed ID: 16702958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling.
    Ritt DA; Monson DM; Specht SI; Morrison DK
    Mol Cell Biol; 2010 Feb; 30(3):806-19. PubMed ID: 19933846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of platelet-derived growth factor-induced Ras signaling by poliovirus receptor Necl-5 and negative growth regulator Sprouty2.
    Kajita M; Ikeda W; Tamaru Y; Takai Y
    Genes Cells; 2007 Mar; 12(3):345-57. PubMed ID: 17352739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of mutations in a putative Akt phosphorylation motif of B-raf in human cancers.
    Ikenoue T; Kanai F; Hikiba Y; Tanaka Y; Imamura J; Ohta M; Jazag A; Guleng B; Asaoka Y; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Mol Carcinog; 2005 May; 43(1):59-63. PubMed ID: 15791648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G Protein-regulated inducer of neurite outgrowth (GRIN) modulates Sprouty protein repression of mitogen-activated protein kinase (MAPK) activation by growth factor stimulation.
    Hwangpo TA; Jordan JD; Premsrirut PK; Jayamaran G; Licht JD; Iyengar R; Neves SR
    J Biol Chem; 2012 Apr; 287(17):13674-85. PubMed ID: 22383529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
    Wan PT; Garnett MJ; Roe SM; Lee S; Niculescu-Duvaz D; Good VM; Jones CM; Marshall CJ; Springer CJ; Barford D; Marais R;
    Cell; 2004 Mar; 116(6):855-67. PubMed ID: 15035987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.
    Hernandez MA; Patel B; Hey F; Giblett S; Davis H; Pritchard C
    Cell Signal; 2016 Jun; 28(6):561-71. PubMed ID: 26898828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
    Garnett MJ; Rana S; Paterson H; Barford D; Marais R
    Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty2 down-regulation promotes axon growth by adult sensory neurons.
    Hausott B; Vallant N; Auer M; Yang L; Dai F; Brand-Saberi B; Klimaschewski L
    Mol Cell Neurosci; 2009 Dec; 42(4):328-40. PubMed ID: 19683577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprouty2 regulates positioning of retinal progenitors through suppressing the Ras/Raf/MAPK pathway.
    Sun J; Yoon J; Lee M; Hwang YS; Daar IO
    Sci Rep; 2020 Aug; 10(1):13752. PubMed ID: 32792568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.
    Köhler M; Röring M; Schorch B; Heilmann K; Stickel N; Fiala GJ; Schmitt LC; Braun S; Ehrenfeld S; Uhl FM; Kaltenbacher T; Weinberg F; Herzog S; Zeiser R; Schamel WW; Jumaa H; Brummer T
    EMBO J; 2016 Jan; 35(2):143-61. PubMed ID: 26657898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
    Houben R; Ortmann S; Drasche A; Troppmair J; Herold MJ; Becker JC
    J Invest Dermatol; 2009 Feb; 129(2):406-14. PubMed ID: 18650848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.